Koyfin Home > Directory > Health Care > Intellia Thera CS > Cash from Investing Activities

Intellia Thera CS Cash from Investing Activities Chart (NTLA)

Intellia Thera CS annual/quarterly Cash from Investing Activities from 2014 to 2020.
  • Intellia Thera CS Cash from Investing Activities for the quarter ending June 06, 2020 was $93m a 134.05% increase of 125m year over year
  • Intellia Thera CS Cash from Investing Activities for the last 12 months ending June 06, 2020 was $147m a 276.43% increase of 405m year over year
  • Intellia Thera CS Annual Cash from Investing Activities for 2019 was $25m a 1,135.84% increase of 286m from 2018
  • Intellia Thera CS Annual Cash from Investing Activities for 2018 was $-261m a 96.13% decrease of -251m from 2017
  • Intellia Thera CS Annual Cash from Investing Activities for 2017 was $-10m a 38.91% decrease of -4m from 2016
Other Cash Flow Metrics:
  • Intellia Thera CS Cash Flow from Operations for the quarter ending September 09, 2018 was $-12m a -71.08% increase of 9m year over year
  • Intellia Thera CS Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-4m a -189.64% increase of 8m year over year
  • Intellia Thera CS Total Revenue for the quarter ending September 09, 2018 was $7m a 9.99% increase of 1m year over year
View Chart On Koyfin

Quarterly NTLA Cash from Investing Activities Data

06/2020$93m
03/2020$57m
12/2019$28m
09/2019$-32m
06/2019$23m
03/2019$6m
12/2018$-256m
09/2018$-2m
06/2018$-1m
03/2018$-2m

Annual NTLA Cash from Investing Activities Data

2019$25m
2018$-261m
2017$-10m
2016$-6m
2015$-3m
2014$-1m